Citation Impact
Citing Papers
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
2011 Standout
Abolition of Long-Term Stability of New Hippocampal Place Cell Maps by NMDA Receptor Blockade
1998 StandoutScienceNobel
Mutant G-protein-coupled receptors as a cause of human diseases
2004
Ionotropic and metabotropic glutamate receptor structure and pharmacology
2005
Epidermal Merkel cells are mechanosensory cells that tune mammalian touch receptors
2014 StandoutNatureNobel
Molecular cloning and characterization of the rat NMDA receptor
1991 StandoutNature
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
The NMDA receptor antagonists, CPP and γ-l-glutamyl-l-aspartate, selectively block post-training improvement of performance in a Y-maze avoidance learning task
1991
Hoxb8 Is Required for Normal Grooming Behavior in Mice
2002 StandoutNobel
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Behavioral evaluation of mice deficient in GABAB(1) receptor isoforms in tests of unconditioned anxiety
2006
Blockade of NMDA receptors increases cell death and birth in the developing rat dentate gyrus
1994
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
C-terminal ECFP Fusion Impairs Synaptotagmin 1 Function
2004 StandoutNobel
Neuroligin-2 Deletion Selectively Decreases Inhibitory Synaptic Transmission Originating from Fast-Spiking but Not from Somatostatin-Positive Interneurons
2009 StandoutNobel
Synaptic and intrinsic properties of neurons of origin of the perforant path in layer II of the rat entorhinal cortex in vitro
1994
Thalamocortical Oscillations in the Sleeping and Aroused Brain
1993 StandoutScience
Synthetic Molecular Motors and Mechanical Machines
2006 Standout
Behavioral effects of anti-muscarinic, anti-serotonergic, and anti-NMDA treatments: hippocampal and neocortical slow wave electrophysiology predict the effects on grooming in the rat
1999
Mechanisms of Action of Carbamazepine and Its Derivatives, Oxcarbazepine, BIA 2-093, and BIA 2-024
2002
Effects of stress throughout the lifespan on the brain, behaviour and cognition
2009 Standout
A Broken α-Helix in Folded α-Synuclein
2003 StandoutNobel
Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance
1991
Direct Catalytic Asymmetric Three‐Component Kabachnik–Fields Reaction
2008 StandoutNobel
Serine proteases and brain damage – is there a link?
2000
Molecular target size analyses of the NMDA-receptor complex in rat cortex
1989
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
The Rise and Fall of the Chemoattractant Receptor GPR33
2005 StandoutNobel
Sleep Deprivation Effects on Circadian Clock Gene Expression in the Cerebral Cortex Parallel Electroencephalographic Differences among Mouse Strains
2008 StandoutNobel
Neuroligins Determine Synapse Maturation and Function
2006 StandoutNobel
The Competitive NMDA Antagonist CGP 40116 Permanently Reduces Brain Damage after Middle Cerebral Artery Occlusion in Rats
1995
Simultaneous blockade of non‐NMDA ionotropic receptors and NMDA receptor‐associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia
1995
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
More hippocampal neurons in adult mice living in an enriched environment
1997 StandoutNature
Spatial representation and the architecture of the entorhinal cortex
2006 StandoutNobel
Vigabatrin
1991
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
2001
Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation
2006 Standout
Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
2006
Specific roles of GABAB(1) receptor isoforms in cognition
2007
LTP and LTD
2004 Standout
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
2000
The Amyloid State of Proteins in Human Diseases
2012 Standout
Transvascular delivery of small interfering RNA to the central nervous system
2007 Nature
Can molecules explain long-term potentiation?
1999
The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils
1988
Ca2+ Buffer Saturation Underlies Paired Pulse Facilitation in Calbindin-D28k-Containing Terminals
2003
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
2011 Standout
Structural Bases of Desensitization in AMPA Receptor-Auxiliary Subunit Complexes
2017 StandoutNobel
Asymmetric Multicomponent Reactions (AMCRs): The New Frontier
2005 Standout
Don't worry ‘B’ happy!: a role for GABAB receptors in anxiety and depression
2004
Parkinson's Disease
2003 Standout
Glutamate neurotoxicity in spinal cord cell culture
1991
Maltose–neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins
2010 StandoutNobel
Flexible Molecules with Defined Shape—Conformational Design
1992
Ligand-Gated Ion Channels: New Insights into Neurological Disorders and Ligand Recognition
2012
Elucidation of AMPA receptor–stargazin complexes by cryo–electron microscopy
2016 StandoutScienceNobel
Rab3 Superprimes Synaptic Vesicles for Release: Implications for Short-Term Synaptic Plasticity
2006 StandoutNobel
Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors
1995
Potentiation of NMDA Receptor Function by the Serine Protease Thrombin
2000
Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein
2002
Focal Cerebral Ischemia in the Cat: Pretreatment with a Competitive NMDA Receptor Antagonist, D-CPP-ene
1990
Synthesis of β-Aminophosphonates and -Phosphinates
2005
Regio- and stereoselectivity in reactions of 2,3-cis- and trans-3-alkyl-2-vinylaziridines with organocopper reagents: Importance of 2,3-cis-stereochemistry in controlling selectivity
1997
Excitatory glutamate is essential for development and maintenance of the piloneural mechanoreceptor
2012
Flexible Moleküle mit definierter Gestalt — Konformationsdesign
1992
A Century of Alzheimer's Disease
2006 StandoutScience
Molecular constituents of neuronal AMPA receptors
2005
Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy
2006
Molecular Genetic Advances in Sleep Research and Their Relevance to Sleep Medicine
2005
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
The Effects of a Competitive NMDA Receptor Antagonist (CGS-19755) on Cerebral Blood Flow and pH in Focal Ischemia
1991
Cellular and Molecular Mechanisms of Drug Dependence
1988 StandoutScience
Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches
2013 StandoutNobel
Artificial Molecular Machines
2015 Standout
Catalytic Asymmetric Conjugate Addition and Allylic Alkylation with Grignard Reagents
2008 StandoutNobel
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
1999 StandoutScience
Neuropathology in mice expressing human alpha-synuclein
2000
Ischemic Cell Death in Brain Neurons
1999 Standout
Anticonvulsant activity of glycine-site NMDA antagonists. 2. trans 2-carboxy-4-substituted tetrahydroquinolines.
1993
Regulation of adult neurogenesis by excitatory input and NMDA receptor activation in the dentate gyrus
1995
Pharmacology of the Na v 1.1 domain IV voltage sensor reveals coupling between inactivation gating processes
2017 StandoutNobel
Nav1.1 Modulation by a Novel Triazole Compound Attenuates Epileptic Seizures in Rodents
2014
Synthesis and evaluation of 5,7‐dichloro‐4‐(3‐{4‐[4‐(2‐[18F]fluoroethyl)‐piperazin‐1‐yl]‐phenyl}‐ureido)‐1,2,3,4‐tetrahydroquinoline‐2‐carboxylic acid as a potential NMDA ligand to study glutamatergic neurotransmission in vivo
2003
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
1997
Activation of Microglial Group III Metabotropic Glutamate Receptors Protects Neurons against Microglial Neurotoxicity
2003
Emerging Targets in Photopharmacology
2016 StandoutNobel
Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation
1996 Standout
Recent developments in the stereoselective synthesis of α-aminoacids
1994
Synthesis and N‐Methyl‐D ‐aspartate (NMDA) Antagonist Properties of the Enantiomers of α‐Amino‐5‐(phosphonomethyl)[1,1′‐biphenyl]‐3‐propanoic Acid. Use of a New Chiral Glycine Derivative
1992
Rufinamide Attenuates Mechanical Allodynia in a Model of Neuropathic Pain in the Mouse and Stabilizes Voltage-gated Sodium Channel Inactivated State
2012
Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant α-Synuclein in Human and Transgenic Mouse Brain
2000
Aryl−Aryl Bond Formation One Century after the Discovery of the Ullmann Reaction
2002 Standout
Genetic evidence for a protein-kinase-A-mediated presynaptic component in NMDA-receptor-dependent forms of long-term synaptic potentiation
2005 StandoutNobel
AMPA receptors as a molecular target in epilepsy therapy
2013
Physiology of Microglia
2011 Standout
Molecular Diversity of Glutamate Receptors and Implications for Brain Function
1992 StandoutScience
Reversal of the anti-conflict action of valproate by various GABA and benzodiazepine antagonists
1984
Asymmetric Transition-Metal-Catalyzed Allylic Alkylations: Applications in Total Synthesis
2003 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Markus Schmutz being referenced
(R, S)-4-Phosphonophenylglycine, a Potent and Selective Group III Metabotropic Glutamate Receptor Agonist, Is Anticonvulsive and Neuroprotective In Vivo
1999
CGP 37849 and CGP 39551: novel and potent competitive N‐methyl‐d ‐aspartate receptor antagonists with oral activity
1990
The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models
2008
?-Vinyl GABA: comparison of neurochemical and anticonvulsant effects in mice
1988
Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity
2011
GABAB receptors in various in vitro and in vivo models of epilepsy: A study with the GABAB receptor blocker CGP 35348
1992
5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition
2002
Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters
1995
Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum
1996
Oxcarbazepine: Preclinical Anticonvulsant Profile and Putative Mechanisms of Action
1994
The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents
1990
Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures
1994
N-Phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: In vivo active AMPA and NMDA(glycine) antagonists
1999
Specific γ‐hydroxybutyrate‐binding sites but loss of pharmacological effects of γ‐hydroxybutyrate in GABAB(1)‐deficient mice
2003
Oxcarbazepine: Mechanisms of Action
1994
Global Down-Regulation of Gene Expression in the Brain Using RNA Interference, with Emphasis on Monoamine Transporters and GPCRs: Implications for Target Characterization in Psychiatric and Neurological Disorders
2006
AMPA Receptor Antagonists: Potential Therapeutic Applications
2006
Synthesis, radiolabelling and biological characterization of (d)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors
2000
Endogenous Serine Protease Inhibitor Modulates Epileptic Activity and Hippocampal Long-Term Potentiation
1997
CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.
1988
THE EFFECT OF SODIUM‐n‐DIPROPYL ACETATE ON γ‐AMINOBUTYRIC ACID‐DEPENDENT INHIBITION IN THE RAT CORTEX AND SUBSTANTIA NIGRA IN RELATION TO ITS ANTICONVULSANT ACTIVITY
1980
CGP 37849 and CGP 39551: novel competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activity.
1990
Increased Seizure Susceptibility in Mice Lacking Metabotropic Glutamate Receptor 7
2001